Clinical Trials Browser

Phase 1/2 × Sarcoma × retrovector encoding mutant anti-cyclin G1 × Clear all

NCT00505713 2011-06-10

Safety and Efficacy Study Using Rexin-G for Sarcoma

Phase 1/2 Completed

Sarcoma